DD Support Board and Research Team

[goodthings]

A moderator on the DECN board said to a basher: "None of the internal happenings makes a bit of difference to traders. The share price running is all anyone is concerned with."

I think this is the immutable truth in the OTC stock world.

I rarely visit stock boards, but I happened to visit the DECN board. Now, about three times a week since then. To put up with the hypothetical CEO is ........ I thought of this after reading the press releases.


In early April the company (DECN) filed its EUA application for a antibody test kit named 'Genviro COVID-19 Swift kit' used in professionally administered settings; results will be available in about 15 sconds using a finger prick sample.

They announced that as soon as they get the EUA from the FDA,the Genviro Swift test kit strip will go into production.

The CEO has made 12 press releases with certainty. He even boasted a high accuracy rate of the test kit for COVID-19. They use an odd diagnostic technique not validated by experts in the field. --- No matter how hard Mr. President has urged the FDA to relax the rules owing to the urgency of the situation, they should not do things that do more harm than good.

In the Tuesday April 21st PR, the CEO of DECN stated "Our Genviro COVID-19 test kit is currently in the FDA EUA review process. Our sister product, Genviro at-home use kit is now in the process of completing our FDA EUA application." -- Also he mentioned he would release another PR on Thursday April 23.


The CEO of DECN is deceiving shareholders.

The FDA has NOT granted the EUA for any 'at-home-finger prick blood test kit' for COVID-19 so far because of an accuracy issue.

Even though the CEO is well aware of the fact that the FDA will NOT approve the EUA for 'home-test kits', he re-released such absurd news this Tuesday. After submitting the application for 'at-home use kit, two more PRs will be released as usual. --- Maybe in order to buy time to sell off the over 50million shares he issued in March. According to a poster, the CEO said to him, "I am not issuing any new shares." Sounds like Greg Rotman (VYST).


Feb. 27, 2020: Volume- 1,351 / Closing price- 0.0175
Feb. 28, 2020: Volume- 981
March 2: Volume- 152

From March 3 to this Tuesday April 21, the CEO published 12 PRs on plans for antibody test kits for COVID-19.

March 3: Volume- 180,023 / Closing price- 0.0313
March 4, 3/11, 3/16, 3/17, 3/18, 3/20, 3/23, 3/25,
April 6, 4/7, 4/21 & Today 4/23

NB: The stock prices fell for two consecutive days because of the uncertainty, the anxiety about not getting the EUA approval.
So the CEO released insubstantial news again on Tuesday.



The initial immune response is characterized by the appearance of neutralizing antibodies of the lgM class. -- (lg is an abbreviation for immunoglobulin.) lgM antibodies appear earlier and decline more rapidly than lgG antibodies. Antibody tests, lgM tests are widely used for the diagnosis of acute infections. Can you still say that a 'Home test kit' using a finger prick is reliable?

Considering the CEO of DECN uses the odd diagnostic test for COVID-19, there is a possibility that the company will make "crappy" antibody test kits without the EUA from the FDA and sell them to poor countries. --- European countries will no longer be deceived.

Around 70 COVID-19 antibody tests had been developed in March all over the world. Now?? Even more.

Here is an example of error-prone antibody test kits: The British government imported 3.5 million antibody test kits, but they did not work, so they requested a refund.

https://www.theguardian.com/world/2020/apr/09/uk-government-urged-to-abandon-poor-finger-prick-antibody-tests-coronavirus


I think the CEO of DECN is really bad. To be honest with you, I hope ihub people make a lot money. Don't listen to the male cheerleaders, though.



Have a nice day!


An antibody test known as a serology test misses early infections of COVID-19, so that the results can be wrong.

However, I think antibody testing is useful for people who have recovered from COVID-19.

SARS-COV-2 causes COVID-19. When the novel coronavirus invades the body, the immune system produces different antibodies. The problem is that SARS-COV-2 has acquired mutations capable of substantially changing the pathogen. -- About 4,300 mutations worldwide so far. I think this will make it harder to develop treatments and vaccines for COVID-19.

Negative as it may sound, it is said that COVID-19 will "restart" this late fall with the flu.

An individual's immune status is different. If you have underlying diseases such as high blood pressure, diabetes, bronchial diseases, etc, you should be especially careful.

Viruses enter through the eyes, nose or mouth,so do not touch your face with your hands. Let's wash our hands well. Wear a face mask outside for me and others even if it is uncomfortable.
--- There are many people who are asymptomatic.

I expect effective treatments to be developed sooner or later.

I think the Nobel Prize in Medicine should go to those who have contributed the most to developing great vaccines.